Pro-inflammatory cytokines increase temporarily after adjuvant treatment for breast cancer in postmenopausal women: a longitudinal study

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.

Article  PubMed  Google Scholar 

Altun İ, Sonkaya A. The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health. 2018;47:1218–9.

PubMed Central  PubMed  Google Scholar 

Trédan O, Bajard A, Meunier A, et al. Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr. 2010;29:187–91.

Article  PubMed  Google Scholar 

Buch-Larsen K, Lund-Jacobsen T, Andersson M, Schwarz P. Weight change in post-menopausal women with breast cancer during chemotherapy-perspectives on nutrition, activity and bone metabolism: an interim analysis of a 5-year prospective cohort. Nutrients. 2021;13(8):2902. https://doi.org/10.3390/nu13082902.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38:27–43.

Article  CAS  PubMed  Google Scholar 

Ryu HH, Ahn SH, Kim SO, et al. Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer. Sci Rep. 2021;11:10510.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Kwan ML, Cheng RK, Iribarren C, et al. Risk of cardiometabolic risk factors in women with and without a history of breast cancer: the pathways heart study. J Clin Oncol. 2022;40:1635–46.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Dixon JK, Moritz DA, Baker FL. Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum. 1978;5:5–7.

CAS  PubMed  Google Scholar 

Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1993;11:1418–29.

Article  CAS  PubMed  Google Scholar 

Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344:1997–2008.

Article  CAS  PubMed  Google Scholar 

Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347–55.

Article  CAS  PubMed  Google Scholar 

Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the american heart association. Circulation. 2021;143:e984–1010.

Article  PubMed Central  PubMed  Google Scholar 

Ruparelia N, Chai JT, Fisher EA, Choudhury RP. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol. 2017;14:133–44.

Article  CAS  PubMed  Google Scholar 

Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.

Article  CAS  PubMed  Google Scholar 

Mehta LS, Watson KE, Barac A, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the american heart association. Circulation. 2018;137:e30–66.

Article  PubMed Central  PubMed  Google Scholar 

Jakobsen M, Kolodziejczyk C, Jensen MS, Poulsen PB, Khan H, Kümler T, Andersson M. Cardiovascular disease in women with breast cancer - a nationwide cohort study. BMC Cancer. 2021;21:1040.

Article  PubMed Central  PubMed  Google Scholar 

Afifi AM, Saad AM, Al-Husseini MJ, Elmehrath AO, Northfelt DW, Sonbol MB. Causes of death after breast cancer diagnosis: a US population-based analysis. Cancer. 2020;126:1559–67.

Article  PubMed  Google Scholar 

Abdel-Qadir H, Austin PC, Lee DS, Amir E, Tu JV, Thavendiranathan P, Fung K, Anderson GM. A population-based study of cardiovascular mortality following early-stage breast cancer. JAMA Cardiol. 2017;2:88–93.

Article  PubMed  Google Scholar 

Jabeen S, Espinoza JA, Torland LA, et al. Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology. 2019;8: e1537691.

Article  PubMed  Google Scholar 

Kawaguchi K, Sakurai M, Yamamoto Y, et al. Alteration of specific cytokine expression patterns in patients with breast cancer. Sci Rep. 2019;9:2924.

Article  PubMed Central  PubMed  Google Scholar 

Jabeen S, Zucknick M, Nome M, et al. Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. 2018;7:e1457598.

Article  PubMed Central  PubMed  Google Scholar 

Marconi R, Serafini A, Giovanetti A, Bartoleschi C, Pardini MC, Bossi G, Strigari L. Cytokine modulation in breast cancer patients undergoing radiotherapy: a revision of the most recent studies. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20020382.

Article  PubMed Central  PubMed  Google Scholar 

Bower JE, Ganz PA, Irwin MR, et al. Acute and chronic effects of adjuvant therapy on inflammatory markers in breast cancer patients. JNCI Cancer Spectr. 2022. https://doi.org/10.1093/jncics/pkac052.

Article  PubMed Central  PubMed  Google Scholar 

Aula H, Skyttä T, Tuohinen S, Luukkaala T, Hämäläinen M, Virtanen V, Raatikainen P, Moilanen E, Kellokumpu-Lehtinen P-L. Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer. Radiat Oncol. 2018;13:201.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Schmidt ME, Meynköhn A, Habermann N, et al. Resistance exercise and inflammation in breast cancer patients undergoing adjuvant radiation therapy: mediation analysis from a randomized, controlled intervention trial. Int J Radiat Oncol Biol Phys. 2016;94:329–37.

Article  PubMed  Google Scholar 

Zhang Z, Ormiston K, Schnell P, Kopec R, Lustberg M, Orchard T. Changes in serum fatty acids and inflammatory markers in postmenopausal women with breast cancer following chemotherapy treatment. Curr Dev Nutr. 2021;5:290.

Article  PubMed Central  Google Scholar 

Cheung YT, Ng T, Shwe M, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol Off J Eur Soc Med Oncol. 2015;26:1446–51.

Article  CAS  Google Scholar 

Lyon DE, Cohen R, Chen H, Kelly DL, McCain NL, Starkweather A, Ahn H, Sturgill J, Jackson-Cook CK. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol. 2016;301:74–82.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Dieli-Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. 2016;122:2646–53.

Article  CAS  PubMed  Google Scholar 

Hu JJ, Urbanic JJ, Case LD, et al. Association between inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in a multiracial/ethnic breast cancer population. J Clin Oncol. 2018;36:2473–82.

Article  CAS  PubMed Central  PubMed 

留言 (0)

沒有登入
gif